NDC Package 23155-258-41 Adenosine

Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
23155-258-41
Package Description:
10 VIAL in 1 CARTON / 20 mL in 1 VIAL
Product Code:
Proprietary Name:
Adenosine
Non-Proprietary Name:
Adenosine
Substance Name:
Adenosine
Usage Information:
Adenosine injection, USP is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately.
11-Digit NDC Billing Format:
23155025841
NDC to RxNorm Crosswalk:
  • RxCUI: 1654035 - adenosine 60 MG in 20 mL Injection
  • RxCUI: 1654035 - 20 ML adenosine 3 MG/ML Injection
  • RxCUI: 1654035 - adenosine 60 MG per 20 ML Injection
  • RxCUI: 1654040 - adenosine 90 MG in 30 mL Injection
  • RxCUI: 1654040 - 30 ML adenosine 3 MG/ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA202313
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-01-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    23155-258-311 VIAL in 1 CARTON / 20 mL in 1 VIAL
    23155-258-321 VIAL in 1 CARTON / 30 mL in 1 VIAL
    23155-258-4210 VIAL in 1 CARTON / 30 mL in 1 VIAL

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 23155-258-41?

    The NDC Packaged Code 23155-258-41 is assigned to a package of 10 vial in 1 carton / 20 ml in 1 vial of Adenosine, a human prescription drug labeled by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 23155-258 included in the NDC Directory?

    Yes, Adenosine with product code 23155-258 is active and included in the NDC Directory. The product was first marketed by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc. on March 01, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 23155-258-41?

    The 11-digit format is 23155025841. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-223155-258-415-4-223155-0258-41